39 min

Ep 9 - KT Case Study: mRNA Vaccine (ft. Dr. Pieter Cullis‪)‬ RAINCOAT Conversations

    • Life Sciences

How can bench science be translated into the real world? What are other opportunities that are currently available beyond academia? How did collaborations and team building play a role in the development of the COVID-19 mRNA-based vaccines? 

Today, join the hosts, Sarah & Isabelle, as they dive into what went into the science of developing the mRNA vaccines (e.g., Moderna, Pfizer) with Dr. Pieter Cullis

🎙 Guest:


Dr. Pieter Cullis - Email | Nanomedicines Research Group

👉 Stay connected with Raincoat Podcast - Twitter | Email

How can bench science be translated into the real world? What are other opportunities that are currently available beyond academia? How did collaborations and team building play a role in the development of the COVID-19 mRNA-based vaccines? 

Today, join the hosts, Sarah & Isabelle, as they dive into what went into the science of developing the mRNA vaccines (e.g., Moderna, Pfizer) with Dr. Pieter Cullis

🎙 Guest:


Dr. Pieter Cullis - Email | Nanomedicines Research Group

👉 Stay connected with Raincoat Podcast - Twitter | Email

39 min